These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23789633)

  • 1. Investigation of the esophageal Rho-kinase expression in patients with Barrett's esophagus.
    Demiryürek S; Koruk I; Bozdag Z; Ozkara E; Kaplan DS; Oztuzcu S; Cetinkaya A; Alasehirli B; Demiryürek AT
    Ultrastruct Pathol; 2013 Aug; 37(4):284-9. PubMed ID: 23789633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho Kinase ROCK2 Mediates Acid-Induced NADPH Oxidase NOX5-S Expression in Human Esophageal Adenocarcinoma Cells.
    Hong J; Li D; Cao W
    PLoS One; 2016; 11(2):e0149735. PubMed ID: 26901778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
    Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
    Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
    Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
    Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.
    Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K
    J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of inducible nitric oxide synthase is increased in rat Barrett's esophagus induced by duodenal contents reflux.
    Bae JD; Jung KH; Ahn WS; Bae SH; Jang TJ
    J Korean Med Sci; 2005 Feb; 20(1):56-60. PubMed ID: 15716603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
    Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
    Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
    Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
    J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of rho-kinase gene polymorphisms and protein expressions in colorectal cancer development.
    Sari I; Berberoglu B; Ozkara E; Oztuzcu S; Camci C; Demiryurek AT
    Pathobiology; 2013; 80(3):138-45. PubMed ID: 23328676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dickkopf homologs in squamous mucosa of esophagitis patients are overexpressed compared with Barrett's patients and healthy controls.
    Ali I; Rafiee P; Hogan WJ; Jacob HJ; Komorowski RA; Haasler GB; Shaker R
    Am J Gastroenterol; 2006 Jul; 101(7):1437-48. PubMed ID: 16863544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
    Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
    Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of mitogen-activated protein kinases in the esophageal epithelium of patients with Barrett's esophagus.
    Chwiesko A; Baniukiewicz A; Semeniuk J; Kaczmarski M; Wasielica-Berger J; Milewski R; Dabrowski A
    Dis Esophagus; 2015; 28(6):585-92. PubMed ID: 24867362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
    J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia.
    van Baal JW; Diks SH; Wanders RJ; Rygiel AM; Milano F; Joore J; Bergman JJ; Peppelenbosch MP; Krishnadath KK
    Cancer Res; 2006 Dec; 66(24):11605-12. PubMed ID: 17178854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
    Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.